In vivo performance of a novel silk fibroin scaffold for partial meniscal replacement in a sheep model.

Authors:
Katharina Gruchenberg
Katharina Gruchenberg
Institute of Orthopaedic Research and Biomechanics
Germany
Anita Ignatius
Anita Ignatius
University of Ulm
Germany
Benedikt Friemert
Benedikt Friemert
Institute of Orthopaedic Research and Biomechanics
Germany
Nick Skaer
Nick Skaer
University of Cambridge
United Kingdom
Kris Gellynck
Kris Gellynck
UCL Eastman Dental Institute
United Kingdom
Oliver Kessler
Oliver Kessler
University of Zurich
Switzerland

Knee Surg Sports Traumatol Arthrosc 2015 Aug 26;23(8):2218-2229. Epub 2014 Apr 26.

Institute of Orthopaedic Research and Biomechanics, Centre of Musculoskeletal Research, University of Ulm, Helmholtzstraße 14, 89081, Ulm, Germany.

Purpose: Due to the negative effects of meniscectomy, there is a need for an adequate material to replace damaged meniscal tissue. To date, no material tested has been able to replace the meniscus sufficiently. Therefore, a new silk fibroin scaffold was investigated in an in vivo sheep model.

Methods: Partial meniscectomy was carried out to the medial meniscus of 28 sheep, and a scaffold was implanted in 19 menisci (3-month scaffold group, n = 9; 6-month scaffold group, n = 10). In 9 sheep, the defect remained empty (partial meniscectomy group). Sham operation was performed in 9 animals.

Results: The silk scaffold was able to withstand the loads experienced during the implantation period. It caused no inflammatory reaction in the joint 6 months postoperatively, and there were no significant differences in cartilage degeneration between the scaffold and sham groups. The compressive properties of the scaffold approached those of meniscal tissue. However, the scaffolds were not always stably fixed in the defect, leading to gapping between implant and host tissue or to total loss of the implant in 3 of 9 cases in each scaffold group. Hence, the fixation technique needs to be improved to achieve a better integration into the host tissue, and the long-term performance of the scaffolds should be further investigated.

Conclusion: These first in vivo results on a new silk fibroin scaffold provide the basis for further meniscal implant development. Whilst more data are required, there is preliminary evidence of chondroprotective properties, and the compressive properties and biocompatibility are promising.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00167-014-3009-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661201PMC

Still can't find the full text of the article?

Sign up to send a request to the authors directly.
August 2015
24 Reads

Publication Analysis

Top Keywords

scaffold group
12
fibroin scaffold
12
silk fibroin
12
scaffold
10
meniscal tissue
8
partial meniscectomy
8
compressive properties
8
host tissue
8
sham groups
4
postoperatively differences
4
differences cartilage
4
degeneration scaffold
4
groups compressive
4
cartilage degeneration
4
scaffold sham
4
scaffold approached
4
stably fixed
4
fixed defect
4
scaffolds stably
4
tissue scaffolds
4

References

(Supplied by CrossRef)
Article in Biomaterials
GH Altman et al.
Biomaterials 2003
Article in Biomaterials
GH Altman et al.
Biomaterials 2002
Article in Arthroscopy
H Andersson-Molina et al.
Arthroscopy 2002
Article in Expert Rev Med Devices
P Buma et al.
Expert Rev Med Devices 2007
Article in Lab Anim
C Burger et al.
Lab Anim 2007
Article in J Orthop Res
HN Chia et al.
J Orthop Res 2008
Article in Osteoarthr Cartil
C Chiari et al.
Osteoarthr Cartil 2006
Article in Clin Orthop Relat Res
JS Cox et al.
Clin Orthop Relat Res 1975
Article in Clin Biomech
L Dürselen et al.
Clin Biomech 2003
Article in Knee Surg Sports Traumatol Arthrosc
T Efe et al.
Knee Surg Sports Traumatol Arthrosc 2011
Article in Curr Stem Cell Res Ther
B Haddad et al.
Curr Stem Cell Res Ther 2013

Similar Publications

An Analytical Study of Electromagnetic Deep Penetration Conditions and Implications in Lossy Media through Inhomogeneous Waves.

Materials (Basel) 2018 Sep 3;11(9). Epub 2018 Sep 3.

Department of Information Engineering, Electronics and Telecommunications (DIET), Sapienza University of Rome, 00184 Rome, Italy.

This paper illustrates how the penetration of electromagnetic waves in lossy media strongly depends on the waveform and not only on the media involved. In particular, the so-called inhomogeneous plane waves are compared against homogeneous plane waves illustrating how the first ones can generate deep penetration effects. Moreover, the paper provides examples showing how such waves may be practically generated. Read More

View Article
September 2018
10 Reads
2.65 Impact Factor

Thalidomide (5HPP-33) suppresses microtubule dynamics and depolymerizes the microtubule network by binding at the vinblastine binding site on tubulin.

Biochemistry 2015 Mar 17;54(12):2149-59. Epub 2015 Mar 17.

Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai 400076, India.

Thalidomides were initially thought to be broad-range drugs specifically for curing insomnia and relieving morning sickness in pregnant women. However, its use was discontinued because of a major drawback of causing teratogenicity. In this study, we found that a thalidomide derivative, 5-hydroxy-2-(2,6-diisopropylphenyl)-1H-isoindole-1,3-dione (5HPP-33), inhibited the proliferation of MCF-7 with a half-maximal inhibitory concentration of 4. Read More

View Article
March 2015
40 Reads
7 PubMed Central Citations(source)
3.02 Impact Factor

Arginine NO-dependent and NO-independent effects on hemodynamics.

Eur J Pharmacol 2014 Apr 11;729:138-43. Epub 2014 Feb 11.

PROFISIO, Universidad Nacional de Rosario, Argentina; VA Greater Los Angeles Healthcare System, 11301 Wilshire Boulevard, Los Angeles, CA 90073, USA; Department of Physiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina. Electronic address:

L-arginine administration decreases mean arterial blood pressure (MABP), presumably by excess nitric oxide (NO) synthesis. However, some reports indicate that d-arginine, not a substrate of NO synthase (NOS), also induces hypotension. To clarify this phenomenon, the hemodynamic effects of L- and D-arginine and their modification by NOS inhibition with L-nitroarginine methyl ester (L-NAME) were assessed. Read More

View Article
April 2014
17 Reads
2.53 Impact Factor

The role of cryosurgery of the prostate for nonsurgical candidates.

JSLS 2013 Jul-Sep;17(3):423-8

Section of Minimally Invasive Urology, Warren Alpert Medical School of Brown University, 2 Dudley St, Ste 174, Providence, RI 02905, USA.

Introduction: Technological advancements have reduced the morbidity associated with cryosurgery, leading to an increased interest in this modality for the treatment of organ-confined prostate cancer. In this study, we critically examine the current role of cryoablation of the prostate to better understand how to counsel patients regarding this treatment option.

Methods: A database was compiled over a 3-year period (2008-2011) of 30 patients who underwent cryoablation for organ-confined prostate cancer. Read More

View Article
April 2014
10 Reads
4 PubMed Central Citations(source)
0.79 Impact Factor

Analyses of marketplace tacrolimus drug product quality: bioactivity, NMR and LC-MS.

J Pharm Biomed Anal 2013 Nov 12;85:108-17. Epub 2013 Jul 12.

US Food and Drug Administration, CDER, Division of Pharmaceutical Analysis, St. Louis, MO 63101, USA.

Tacrolimus (FK506) is a potent, narrow therapeutic index, immunosuppressive drug used to avoid organ rejection in patients that have undergone organ transplantation. Recent clinical reports suggested a significant reduction in the tacrolimus concentration/dose ratio in the plasma of liver and kidney recipients when the reference listed drug was substituted with a generic drug. In response to these concerns about switching between tacrolimus from different approved manufacturers during treatment, the FDA initiated purity, potency and quality studies of the innovator and generic tacrolimus products available in the US marketplace. Read More

View Article
November 2013
11 Reads
2.98 Impact Factor